Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Nature Communications|October 10, 2019
Context-specific regulation of surface and soluble IL7R expression by an autoimmune risk alleleHussein Al-Mossawi, Nicole Yager, Chelsea A Taylor, et al.Frontiers in Immunology|December 3, 2024
Early immune profiling reveals distinct inflammatory responses between children and adults few days after primary SARS-CoV-2 infectionMartijn D B Van de Garde, Alberto Miranda-Bedate, Nening M Nanlohy, et al.Frontiers in Immunology|February 24, 2022
Children and Adults With Mild COVID-19: Dynamics of the Memory T Cell Response up to 10 MonthsPatricia Kaaijk, Verónica Olivo Pimentel, Maarten E Emmelot, et al.Frontiers in Immunology|May 16, 2022
Corrigendum: Children and Adults With Mild COVID-19: Dynamics of the Memory T Cell Response Up to 10 MonthsPatricia Kaaijk, Verónica Olivo Pimentel, Maarten E Emmelot, et al.The Journal of Infectious Diseases|April 12, 2019
Early Measles Vaccination During an Outbreak in the Netherlands: Short-Term and Long-Term Decreases in Antibody Responses Among Children Vaccinated Before 12 Months of AgeIris D Brinkman, Jelle de Wit, Gaby P Smits, et al.Frontiers in Immunology|May 22, 2024
Distinct T cell responsiveness to different COVID-19 vaccines and cross-reactivity to SARS-CoV-2 variants with age and CMV statusJolanda Brummelman, Sara Suárez-Hernández, Lia de Rond, et al.Vaccine|January 23, 2024
Humoral and cellular immunogenicity, effectiveness and safety of COVID-19 mRNA vaccination in patients with pediatric rheumatic diseases: A prospective cohort studyMohamad Hamad Saied, Joeri W van Straalen, Sytze de Roock, et al.Journal of Autoimmunity|January 9, 2023
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinationsKoos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.BMC Infectious Diseases|May 17, 2023
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activityKoos P J van Dam, Adriaan G Volkers, Luuk Wieske, et al.Annals of the Rheumatic Diseases|November 10, 2022
Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseasesEileen W Stalman, Luuk Wieske, Koos P J van Dam, et al.Pageof 5